We used CD68 immunofluorescence to detect macrophages in our TMAs and found CD68+ macrophages present in all tumor TMA spots of NSCLC cohorts (n = 240) in both the TI and TME (Figure 4D). This evidence concerns the gene CD68 and non-small cell lung carcinoma.